Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria.
作者： N.J White , P.L Olliaro
DOI: 10.1016/0169-4758(96)10055-7
关键词:
摘要: Abstract Among the several ‘tropical' diseases that affect humans, malarin poses special control problems due to increasing population at risk from disease, difficulties in eradicating mosquito vector tropics and emergence spread of parasite resistance commonly used antimalarial drugs. There is both clinical experience experimental evidence that, however effective when first introduced, lifespan drugs inevitably curtailed by resistant parasites. Resistance most important factor determining useful In this review, Nick White Piero Olliaro discuss rationale for combination chemotherapy.
tropmedres.ac
elsevier.com参考文章(38)
Jacques Grosset, Bacteriologic basis of short-course chemotherapy for tuberculosis. Clinics in Chest Medicine. ,vol. 1, pp. 231- 241 ,(1980) , 10.1016/S0272-5231(21)00072-1
F.O. ter Kuile, F. Nosten, T. Chongsuphajaisiddhi, N.J. White, G. Dolan, C. Luxemburger, L. Phaipun, M.D. Edstein, H.K. Webster, Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria The Lancet. ,vol. 341, pp. 1044- 1049 ,(1993) , 10.1016/0140-6736(93)92409-M
D. Sturchler, M. Macdonald, D. F. Wirth, D. B. Johnston, W. Rooney, A. M. Walker, M. Hours, A. L. Fontanet, K. Thimasarn, High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand Bulletin of The World Health Organization. ,vol. 71, pp. 377- 383 ,(1993)
Wallace Peters, Chemotherapy and drug resistance in malaria ,(1970)
W Sirawaraporn, P Prapunwattana, R Sirawaraporn, Y Yuthavong, D.V. Santi, The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants. Journal of Biological Chemistry. ,vol. 268, pp. 21637- 21644 ,(1993) , 10.1016/S0021-9258(20)80589-4
Hugo L. David, Probability Distribution of Drug-Resistant Mutants in Unselected Populations of Mycobacterium tuberculosis Applied Microbiology. ,vol. 20, pp. 810- 814 ,(1970) , 10.1128/AM.20.5.810-814.1970
Sornchai Looareesuwan, David B. Hutchinson, Chaisin Viravan, Dennis E. Kyle, Craig J. Canfield, H. Kyle Webster, Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in Thailand American Journal of Tropical Medicine and Hygiene. ,vol. 54, pp. 62- 66 ,(1996) , 10.4269/AJTMH.1996.54.62
L. Lege-Oguntoye, S.I. Adagu, B. Werblinska, W.N. Ogala, A.B. Slotboom, Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semi-immune children in Zaria, northern Nigeria. Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 84, pp. 505- 506 ,(1990) , 10.1016/0035-9203(90)90016-8
Joan Garcia-Vidal, Jean de D. Ngirabega, Montserrat Soldevila, Roser Navarro, JoséLuis Bada, Evolution of resistance of Plasmodium falciparum to antimalarial drugs in Rwanda, 1985-1987. Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 83, pp. 490- 490 ,(1989) , 10.1016/0035-9203(89)90262-9
D. S. Peterson, W. K. Milhous, T. E. Wellems, Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 3018- 3022 ,(1990) , 10.1073/PNAS.87.8.3018